A delayed-start design has been proposed to assess a potential disease-modifying effect in investigational drugs for Alzheimer’s disease that target the underlying disease process. EXPEDITION3 was a Phase 3, double-blind study with participants randomized to solanezumab (400 mg) or placebo… Continue Reading →
Over this century we can expect to see older persons live longer, be more resilient and less frail. Research and care have been built to identify and treat diseases, but not to maintain functional capacities (eg, mobility, cognition, immune functions,… Continue Reading →
Herewith the link to the Integrated Care for Older People (ICOPE) Guidelines http://apps.who.int/iris/bitstream/10665/258981/1/9789241550109-eng.pdf?ua=1 published by the World Health Organisation. These evidence-based recommendations for healthcare professionals aim to prevent, slow or reverse declines in the physical and mental capacities of older… Continue Reading →
© 2025 Aging-news